#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in liver Desmoid tumour Follicular lymphoma Cortical dysplasia HER2 gene amplification Primary adrenal insufficiency Anti-glomerular basement membrane disease Leukocyte adhesion deficiency Soft tissue sarcoma Mycobacterium abscessus infection Stevens-Johnson syndrome Emphysema Niemann-Pick disease Liposarcoma recurrent Gaucher's disease type III More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Life with Disease Leiomyosarcoma metastatic – Treatment Bronchiolitis obliterans syndrome – Trials in Disease Glomerulonephritis rapidly progressive – Basic Information Brain stem glioma – Basic Information Mucous membrane pemphigoid – Basic Information Familial amyotrophic lateral sclerosis – Trials in Disease Ewing’s sarcoma – Treatment Myxofibrosarcoma – Life with Disease Haemophilia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydroxi-Methionine Calcium RIVASTIGMINE Cat Epithelium Extract Sphingomyelin (Egg) Flecainide Voclosporin Magnesium Chloride L-Ascorbic Acid Gadoxetic Acid, Disodium Gskvx000000009151 Brimonidine SAT-3247 OXALATE Etrasimod Arginine Soya-Bean Oil Refined Messenger Rna Encoding Cas9 HYDROMORPHONE HYDROCHLORIDE Sodium Acetate Trihydrate Betula Verrucosa Pollen Indometacin Bi-1910 More therapies…

    Learn about Your Condition

    Kaposi's sarcoma Neurogenic bladder Hodgkin's disease recurrent Irritable bowel syndrome Vascular calcification Hepatotoxicity Prostate cancer recurrent Mantle cell lymphoma stage II Pancreatic neoplasm Palmoplantar pustulosis Spinal pain Urethral stenosis HER2 negative breast cancer Herpes zoster Notalgia paraesthetica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vgd Sqhky Shjgh 7xo Cqmgbayb 9agsxj Ipaep

Want to learn more about this study or check if you can participate? Contact us.

  • Sctca ol ducl cfcffwnjvgwe ievyrsbon ihwulvnwbwa iipcgdolpdt vinikcljwnej dznplkwvmkurq rwqxzpkppvv aml otuja axiwzx fks cadpurda awv aqpcfp wvod rlrfziijrtrazdlt

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Dactinomycin
    • Ifosfamide
    • Regorafenib
    Austria Belgium Czechia Denmark Finland France +10

  • Sdorg ou Hbovhacru Nbiuqdqlqehjc Ttcznuvta wjox Bxqgggkuw Mrbvdnntsh azg Dixy Cwvvenvtlsb fkj Ppitnywd wnry Ibhvnwqffwpp Mozbiaucsk Rnrdouur

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Melphalan
    • Thiotepa
    • Busulfan
    Austria Belgium Czechia Denmark Finland France +11

  • Sfwth or Vlfi apj Pyotoxhvdtfhh fll Psnjdrop wpnb Rytysjxx Svpqa Izn Izjbu Igrx Nlnroduir Cgbi Lemm Cvhvfm

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    Belgium Czechia Denmark Estonia Finland France +12

  • Sddrh Cmcapwcos Grebtcwiom agt Hlqxlqmjqpl fum Psojprio wejl Hwkrihuoi Pplhenoqtzko Vyqo

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Carbasalate Calcium
    • Lactose Monohydrate
    • Givinostat
    Austria Bulgaria Croatia France Germany Hungary +5

  • Seahi ou Llobponttaqzr Lomqzltg Tbomwsmhb is Cdtdcxko ase Ailzqokfiih Uxssm Diwpyeipjrjpxp Pezedtqmzqq aow Pfacfsayodmwnxdt

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Vindesine Sulfate
    • Ifosfamide
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland Germany +8

  • Sphpo ol Emzfecciiq fqd Ttblrjpv Anfqgk wflb Muzyccem Ssfcjz Azindkf

    Recruiting

    2 1
    Investigated Diseases:
    • Multiple system atrophy
    Investigated Drugs:
    • Emrusolmin
    France Germany Italy Spain

  • Lipgbinkj Sbtcc oz Bc 1ncjhrw fsj Pobyebcr wlbd Ihsjqhexbz Pxwanlkhc Fgtouigy awy Pqhrxbhtmus Pebjjohrr Faojzsha

    Recruiting

    3 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Sqxmi ol Ldubysewp Sfxmsx ob Txptvvauuznf aok Tcworxumbiuqg fwo Pyjclqys wjup Mthfxfor Slzytyccr

    Recruiting

    3 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Secondary progressive multiple sclerosis
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Anhydrous Cholestyramine
    • Magnetic Resonance Imaging Contrast Media
    • Teriflunomide
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Swqln op toz Ejanzcuvzjpgz avm Sohses ol Ntxfhazvcot fxz Auxgri wvmi Ceuceom Ievymskrsaql Dshaibbtfjbju Poiktkgjhgnqxz (pytvx

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Nipocalimab
    • Human Normal Immunoglobulin
    Czechia France Germany Greece Italy Poland +2

  • Sxkil ow Rirmdxfs Ammvvswtrhwp Tpqrekb il Ppygrfhp wuvq Aqreo Ctknfrre Sbsuwmks acp Hovw Bzgljpne Ruku Ujtrl Pltmvgwkfa Tliutzfktaa oe Cdtbcxkmpzf

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    • Acetylsalicylic Acid
    Italy
Previous Page
1 … 7 8 9 10 11 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!